| |
Latter Phase Biomarker Validation and Monitoring Services
Once discovered, Nucleic Acid Biomarkers can be validated using our FDA GLP-level services, which can provide you with FDA submission-quality reports. Additionally, SeqWright offers Biomarker monitoring services in order to detect genetic changes in an individual as a disease progresses. This can provide you with invaluable information regarding treatment efficacy and specificity. We offer the following services:
|
|
FDA-Level DNA Sequencing |
FDA-Level qPCR Expression Analysis |
|
Allelic Discrimination Analysis |
|
Copy Number Variation Studies |
|
|
